133 related articles for article (PubMed ID: 26012225)
1. Study of the role of insulin resistance as a risk factor in HCV related hepatocellular carcinoma.
Ibrahim AA; Abdel Aleem MH; Abdella HM; Helmy A
J Egypt Soc Parasitol; 2015 Apr; 45(1):107-13. PubMed ID: 26012225
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.
Hung CH; Wang JH; Hu TH; Chen CH; Chang KC; Yen YH; Kuo YH; Tsai MC; Lu SN; Lee CM
World J Gastroenterol; 2010 May; 16(18):2265-71. PubMed ID: 20458764
[TBL] [Abstract][Full Text] [Related]
3. INSULIN RESISTANCE REDUCTION AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT ACTING ANTIVIRAL:NOT EVERY POPULATION IMPROVES.
Andrade VG; Yamashiro FDS; Oliveira CV; Moreira A; Winckler FC; Silva GF
Arq Gastroenterol; 2018; 55(3):274-278. PubMed ID: 30540091
[TBL] [Abstract][Full Text] [Related]
4. Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma.
Khattab MA; Eslam M; Mousa YI; Ela-adawy N; Fathy S; Shatat M; Abd-Aalhalim H; Kamal A; Sharawe MA
Ann Hepatol; 2012; 11(4):487-94. PubMed ID: 22700630
[TBL] [Abstract][Full Text] [Related]
5. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P
J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166
[TBL] [Abstract][Full Text] [Related]
7. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
Helaly GF; Hussein NG; Refai W; Ibrahim M
Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients.
Kim JH; Sinn DH; Gwak GY; Kang W; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
J Gastroenterol Hepatol; 2017 May; 32(5):1100-1106. PubMed ID: 27862289
[TBL] [Abstract][Full Text] [Related]
9. Resistin and Insulin Resistance: A Link Between Inflammation and Hepatocarcinogenesis.
Elsayed EY; Mosalam NA; Mohamed NR
Asian Pac J Cancer Prev; 2015; 16(16):7139-42. PubMed ID: 26514502
[TBL] [Abstract][Full Text] [Related]
10. Significance of Serum Adiponectin and Insulin Resistance Levels in Diagnosis of Egyptian Patients with Chronic Liver Disease and HCC.
Radwan HA; Hamed EH; Saleh OM
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1833-1839. PubMed ID: 31244307
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance and prediabetes in hepatitis C virus patients.
Desouky DE; Kasemy Z; Abdel-Hamid AE; Omar MS
Am J Med Sci; 2015 Aug; 350(2):77-80. PubMed ID: 26086154
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.
Desbois AC; Cacoub P
World J Gastroenterol; 2017 Mar; 23(9):1697-1711. PubMed ID: 28321170
[TBL] [Abstract][Full Text] [Related]
14. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
15. Homeostatic Model Assessment of Insulin Resistance for Predicting the Recurrence of Hepatocellular Carcinoma after Curative Treatment.
Imai K; Takai K; Hanai T; Suetsugu A; Shiraki M; Shimizu M
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704150
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
Pekow JR; Bhan AK; Zheng H; Chung RT
Cancer; 2007 Jun; 109(12):2490-6. PubMed ID: 17487861
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus.
Shawky MA; Mohammed AQ; Hassan AM; Ali BH; Moustafa HM
Rev Gastroenterol Mex (Engl Ed); 2020; 85(2):173-179. PubMed ID: 31784195
[TBL] [Abstract][Full Text] [Related]
19. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.
El-Serag HB; Richardson PA; Everhart JE
Am J Gastroenterol; 2001 Aug; 96(8):2462-7. PubMed ID: 11513191
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
